Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Icu Medical (ICUI) over the last 13 years, with Q3 2025 value amounting to -$5.4 million.

  • Icu Medical's Change in Taxes fell 15660.14% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year increase of 6682.26%. This contributed to the annual value of $26.2 million for FY2024, which is 13184.95% up from last year.
  • Icu Medical's Change in Taxes amounted to -$5.4 million in Q3 2025, which was down 15660.14% from -$21.5 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Change in Taxes registered a high of $21.9 million during Q4 2024, and its lowest value of -$39.4 million during Q4 2023.
  • For the 5-year period, Icu Medical's Change in Taxes averaged around -$8.2 million, with its median value being -$6.6 million (2025).
  • Data for Icu Medical's Change in Taxes shows a peak YoY increase of 22047.06% (in 2021) and a maximum YoY decrease of 233162.65% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Icu Medical's Change in Taxes stood at $2.7 million in 2021, then tumbled by 234.17% to -$3.7 million in 2022, then crashed by 969.08% to -$39.4 million in 2023, then surged by 155.48% to $21.9 million in 2024, then crashed by 124.58% to -$5.4 million in 2025.
  • Its Change in Taxes stands at -$5.4 million for Q3 2025, versus -$21.5 million for Q2 2025 and -$6.6 million for Q1 2025.